The Ministry of Health has reported a significant rise in the uptake of the human papillomavirus (HPV) vaccine among Uganda’s young female population.
This positive development, outlined by Dr. Frank Mugabe, Principal Medical Officer in the Ministry of Health’s Non-Communicable Diseases Department, showcases a 150% increase in girls under 14 receiving the first dose. Notably, an 80% success rate for the two-dose regimen has been achieved
“This encouraging news comes as a beacon of hope in the fight against cervical cancer,” Mugabe stated.
Dr. Mugabe attributed this success to a collaborative effort between the Ministry of Health, the Ministry of Education, school administration, and parents. Despite this progress, challenges persist, as some schools are required to seek parental authorization for vaccination, posing a hurdle in rolling out these vital interventions.
Highlighting the significance of HPV vaccination in preventing cervical cancer, Dr. Mugabe emphasized the detrimental consequences of non-vaccination, stressing that unvaccinated girls are at risk of developing cervical cancer in adulthood.
Uganda’s high incidence and mortality rates regarding cervical cancer have prompted the urgent need for such initiatives. The World Health Organization recommends prioritizing girls aged 9-14 years for HPV vaccination, as early vaccination results in a more robust immune response. The success witnessed in Uganda serves as a beacon of hope, demonstrating the efficacy of HPV vaccination when supported by a concerted effort from various stakeholders.
This remarkable achievement not only addresses the immediate health concerns in Uganda but also sets a precedent for other nations, encouraging them to prioritize HPV vaccination and empower young women to proactively safeguard their health.
